Chambers Global Practice Guide on Life Sciences 2020

Published

Apr 05 2020

Written By

I am a partner in our Intellectual Property Group, based in Sydney. My experience spans the breadth and depth of IP issues, but my specialty is complex IP litigation and disputes including contentious patent, trade mark, copyright, and confidential information and consumer protection/passing-off matters.

Jane Owen

Partner
Australia

I'm a partner and head of our Intellectual Property Group in Sydney where I use my deep-level experience of complex IP strategy and disputes to advise clients from a range of IP-rich industries.

Patrick Brown

Associate
UK

I am an Associate in our Intellectual Property Group in London, with a particular focus on the life sciences, pharmaceutical and chemical sectors.

Sectors

Life Sciences and Healthcare

Countries

Australia

Bird & Bird provide practical insights and expert commentary on some key areas of Life Sciences Law in Australia in the 2020 edition of the Chambers Global Practice Guide on Life Sciences. In particular, we examine regulatory frameworks, clinical trials, marketing authorisations, manufacturing of pharmaceutical and medical devices, distribution, import and export, pricing and reimbursement, digital healthcare and intellectual property.

Download the PDF >

Latest insights

More Insights

Relocating production to a new supplier: Legal challenges in the supply chain (upstream and downstream)

3 minutes May 22 2025

UK-India Trade: Opportunities for UK business under the new Free Trade Agreement

3 minutes May 19 2025

Europe's medicine supply crisis: How the EU's bold new act aims to address supply chain vulnerabilities

3 minutes May 14 2025